Brittany Kay
Optometrist · Hubbard, OHNPI 1225679210
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,069 of the $9,353 with a category attached, or 64.9%. 18 manufacturers reported payments, led by Alcon at 30.8% of the total. Reporting peaked in 2024 at $4,310 and has fallen 84.3% since, to $678 in 2025. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $69.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Bausch & Lomb Americas Inc.$2K
- Biotissue Holdings Inc.$2K
- AbbVie$589
- Sun Pharmaceutical Industries Inc.$494
- Oyster Point Pharma, Inc.$357
- plus $1K from 12 others
What the payments were for
- Travel & lodging$3,28435%
- Food & beverage$6,06965%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 28 | $2,884 |
| Bausch & Lomb Americas Inc. | 18 | $2,301 |
| Biotissue Holdings Inc. | 22 | $1,569 |
| AbbVie(2 entities) | 14 | $589 |
| Sun Pharmaceutical Industries Inc. | 17 | $494 |
| Oyster Point Pharma, Inc. | 8 | $357 |
| Kala Pharmaceuticals, Inc. | 5 | $271 |
| Coopervision Inc. | 6 | $270 |
| Tarsus Pharmaceuticals, Inc. | 2 | $182 |
| Dompe US, Inc. | 2 | $107 |
| Lombart Brothers, Inc. | 2 | $61 |
| ABB Con-cise Optical Group LLC | 2 | $59 |
| Sight Sciences, Inc. | 1 | $54 |
| Novartis | 2 | $43 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $36 |
| Johnson & Johnson Vision Care, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $22 |
| Carl Zeiss Meditec USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$1,216
- AmnioGraft$1,216
- DAILIES TOTAL1$252
- INFUSE$250
- Precision 1$246
- Precision7$245
- Hydrus Microstent$245
- LOTEMAX SM$239
- TOTAL30$120
- VYZULTA$120
- VUITY$119
- EYSUVIS$119
- XDEMVY$115
- INFUSE MULTIFOCAL$103
- LUMIGAN$103
How this compares
$9,353 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 17 | $21,177 |
| LumiganBimatoprost | 15 | $11,380 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 15 | $2,662 |
| Latanoprost | 241 | $1,486 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 70 | $1,065 |
| Doxycycline Monohydrate | 26 | $946 |
| Brimonidine Tartrate | 33 | $176 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $169 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 24 | $168 |
| Timolol Maleate | 38 | $159 |
| Dorzolamide Hcl | 17 | $143 |
| Methylprednisolone | 15 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $589 | $32,55732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,995 optometrist providers in Ohio.
Other optometrist in Hubbard
- Mile BrujicBowling Green$1.3M
- Gregory DenaeyerColumbus$846K
- Cory LappinMontgomery$367K
- Chris SmileyColumbus$305K
- Thomas ChesterCleveland$300K
- Carly RoseCincinnati$203K
- Wendy HallierReynoldsburg$200K
- John LahrCincinnati$145K
- Erin RueffColumbus$131K
- Mary YackeyCincinnati$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.